Ditchcarbon
  • Contact
  1. Organizations
  2. Pfizer
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 8 days ago

Pfizer

Company website

Pfizer Inc., a leading global biopharmaceutical company headquartered in the United States, has been at the forefront of medical innovation since its founding in 1849. With a strong presence in North America, Europe, and Asia, Pfizer operates across various sectors, including vaccines, oncology, and rare diseases. The company is renowned for its core products, such as the COVID-19 vaccine and groundbreaking cancer therapies, which leverage advanced biotechnology to address unmet medical needs. Pfizer's commitment to research and development has positioned it as a market leader, consistently achieving significant milestones in drug discovery and patient care. With a robust portfolio and a reputation for quality, Pfizer continues to shape the future of healthcare, making a profound impact on global health outcomes.

DitchCarbon Score

How does Pfizer's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

83

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Pfizer's score of 83 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.

90%

Let us know if this data was useful to you

Pfizer's reported carbon emissions

In 2024, Pfizer reported total emissions of approximately 1,080,000,000 kg CO2e for Scope 1 and 2, while Scope 3 emissions included about 188,000,000 kg CO2e from business travel and approximately 154,000,000 kg CO2e from downstream transportation and distribution. The company has set ambitious targets to reduce its greenhouse gas emissions, committing to a 46% reduction in absolute Scope 1 and 2 emissions by 2030 from a 2019 baseline. This commitment aligns with their goal to procure 100% renewable electricity by 2030. Pfizer also aims to reduce Scope 3 emissions, targeting a 25% reduction in emissions from business travel and a 10% reduction from upstream transportation and distribution by 2025, both from a 2019 baseline. Furthermore, they have pledged that 64% of their suppliers by spend will have science-based targets by 2025. Looking towards the long term, Pfizer has committed to achieving net-zero emissions across its value chain by 2040, with a target to decrease company GHG emissions by 95% and value chain emissions by 90% from 2019 levels. These targets have been approved by the Science Based Targets initiative (SBTi), reinforcing Pfizer's commitment to climate action and sustainability.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2012201320142015201620172018201920202021202220232024
Scope 1
-
-
-
-
-
-
-
-
000,000,000
000,000,000
-
-
-
Scope 2
-
-
-
-
-
-
-
-
000,000,000
000,000,000
-
-
-
Scope 3
-
-
-
-
-
-
-
000,000,000
0,000,000,000
0,000,000,000
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Pfizer's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Pfizer is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Pfizer is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Akums Drugs and Pharmaceuticals Limited

IN
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

Novartis Pharmaceuticals Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 20 days ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

Moderna

US
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Kyorin Pharmaceutical

JP
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251002.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy